Dr. Tashko’s badge from the Better Business Bureau displays an “Accredited Business” seal with an A+ rating as of July 9, 2025 for GT Health practice. The design features the BBB torch logo on the left and a clickable prompt for profile access on the right, reinforcing professional credibility, transparency, and excellence in patient care and business ethics.
🗨️ Text Us Securely

Fees | Join Our Practice

Dr. Tashko's 3D-style illustration representing insulin resistance: a large blue cell with a red “X” symbol, indicating blocked insulin action. Yellow hexagons symbolize glucose molecules. To the right, an insulin vial and syringe highlight the hormone’s impaired function. The background is light blue with bold text reading “INSULIN RESISTANCE” at the top.

Insulin Resistance Care – Background

As a diabetes and weight loss specialist practicing in Rockville, Montgomery County, Maryland, one of my focuses is the holistic approach to diagnosing and managing insulin resistance. I frequently receive questions from my patients about the definition, importance, and therapies for insulin resistance. So, without further ado, let’s explore what insulin resistance entails.

Definition of Insulin Resistance

Insulin resistance is a condition in which the body’s cells become less responsive to the effects of insulin, a hormone produced by the beta cells in the pancreas. Insulin is central for regulating blood sugar (glucose) levels, facilitating the uptake of glucose by cells for energy. When cells develop resistance to insulin, glucose is not efficiently absorbed, leading to elevated blood sugar levels. This, in turn, can result in various medical consequences and complications, as outlined below.

Consequences of Insulin Resistance

  1. Hyperglycemia: Insulin resistance results in decreased effectiveness of insulin, leading to higher levels of glucose in the bloodstream, causing hyperglycemia (high blood sugar).
  1. Type 2 Diabetes: Prolonged insulin resistance can progress to type 2 diabetes, a chronic condition characterized by elevated blood glucose levels due to impaired insulin function.
  1. Metabolic Syndrome: Insulin resistance is a key component of metabolic syndrome, a cluster of conditions that includes abdominal obesity, elevated blood pressure, high blood sugar, and abnormal lipid levels. These factors collectively increase the risk of cardiovascular disease and type 2 diabetes.
  1. Cardiovascular Disease: Insulin resistance contributes to atherosclerosis (hardening of arteries) and increases the risk of heart health deterioration such as coronary artery disease, heart attack, and stroke.
  1. Hypertension: Insulin resistance is associated with an increased risk of hypertension (high blood pressure), which is a significant risk factor for cardiovascular diseases.
  1. Dyslipidemia: Insulin resistance can lead to abnormal lipid (fat) metabolism, resulting in elevated triglyceride levels, reduced HDL (good cholesterol), and an increase in small, dense LDL particles, all of which contribute to dyslipidemia.
  1. NASH (Non-Alcoholic Steatohepatitis): Insulin resistance is a major factor in the development of non-alcoholic fatty liver disease (NAFLD) and its more severe form, NASH, which involves inflammation and damage to the liver.
  1. Weight Gain and Obesity: Insulin resistance can promote weight gain and obesity by disrupting the regulation of fat storage and metabolism.
  1. Polycystic Ovary Syndrome (PCOS): Insulin resistance is often associated with PCOS, a common hormonal disorder in women that can lead to irregular periods, ovarian cysts, and fertility issues.
  1. Hyperuricemia and Gout: Insulin resistance is linked to elevated uric acid levels (hyperuricemia), increasing the risk of gout, a painful inflammatory arthritis caused by the deposition of urate crystals in joints.
  1. Inflammation: Insulin resistance can lead to an increased production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). These cytokines play a key role in promoting chronic low-grade inflammation, which can contribute to the development of various diseases, including cardiovascular disease, diabetes, and NASH.
  1. Cancer: Some studies suggest a link between insulin resistance and an increased risk of certain cancers, such as colon and breast cancers, possibly due to the promotion of cell growth and proliferation.

It is important to note that these complications often interconnect, resulting in a complex network health risks associated with insulin resistance. Lifestyle modifications, including a healthy diet, regular physical activity, and weight management, are essential in managing insulin resistance and reducing its associated complications. Furthermore, medical interventions, such as medications to enhance insulin sensitivity (e.g., GLP-1 agonists like Mounjaro and Ozempic, as well as Metformin), may be prescribed in specific cases.

Dr. Tashko

For Personalized Metabolic Care,
Join Dr. Tashko’s Practice!
Logo for Endocrine ABIM board-certified.

References:

  1. Mechanisms of Insulin Action and Insulin Resistance. Petersen MC, Shulman GI. Physiological Reviews. 2018;98(4):2133-2223. doi:10.1152/physrev.00063.2017.
  2. The Aetiology and Molecular Landscape of Insulin Resistance. James DE, Stöckli J, Birnbaum MJ. Nature Reviews. Molecular Cell Biology. 2021;22(11):751-771. doi:10.1038/s41580-021-00390-6.
  3. Unraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions. Mir MM, Jeelani M, Alharthi MH, et al. International Journal of Molecular Sciences. 2025;26(6):2770. doi:10.3390/ijms26062770.
  4. The Crucial Role and Mechanism of Insulin Resistance in Metabolic Disease. Zhao X, An X, Yang C, et al. Frontiers in Endocrinology. 2023;14:1149239. doi:10.3389/fendo.2023.1149239.
  5. The Pathogenesis of Insulin Resistance: Integrating Signaling Pathways and Substrate Flux. Samuel VT, Shulman GI. The Journal of Clinical Investigation. 2016;126(1):12-22. doi:10.1172/JCI77812.
  6. Insulin Resistance and Insulin Sensitizing Agents. Mastrototaro L, Roden M. Metabolism: Clinical and Experimental. 2021;125:154892. doi:10.1016/j.metabol.2021.154892.
  7. A Glimpse Into Milestones of Insulin Resistance and an Updated Review of Its Management. Aedh AI, Alshahrani MS, Huneif MA, Pryme IF, Oruch R. Nutrients. 2023;15(4):921. doi:10.3390/nu15040921.
  8. Insulin Resistance: Review of the Underlying Molecular Mechanisms. Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Journal of Cellular Physiology. 2019;234(6):8152-8161. doi:10.1002/jcp.27603.
  9. Insulin Signal Transduction Perturbations in Insulin Resistance. Khalid M, Alkaabi J, Khan MAB, Adem A. International Journal of Molecular Sciences. 2021;22(16):8590. doi:10.3390/ijms22168590.
  10. Interorgan Metabolic Crosstalk in Human Insulin Resistance. Gancheva S, Jelenik T, Álvarez-Hernández E, Roden M. Physiological Reviews. 2018;98(3):1371-1415. doi:10.1152/physrev.00015.2017.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is a board-certified endocrinologist based in Montgomery County, Maryland. He is uniquely certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice offers comprehensive, root-cause-focused metabolic and endocrine care, available both virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to optimize long-term health outcomes.

Published

By

Gerti Tashko, MD
Categorized as , , , , , , , , ,